Novavax, Inc.
NVAX
$6.78
$0.182.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -70.55% | -64.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -70.55% | -64.11% | |||
| Cost of Revenue | 29.15% | -22.08% | |||
| Gross Profit | -120.92% | -71.80% | |||
| SG&A Expenses | -13.43% | 11.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.17% | -11.33% | |||
| Operating Income | -175.12% | -79.52% | |||
| Income Before Tax | -288.95% | -79.33% | |||
| Income Tax Expenses | -169.45% | -21.17% | |||
| Earnings from Continuing Operations | -290.01% | -79.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -290.01% | -79.46% | |||
| EBIT | -175.12% | -79.52% | |||
| EBITDA | -164.29% | -78.41% | |||
| EPS Basic | -289.61% | -79.59% | |||
| Normalized Basic EPS | -170.44% | -79.51% | |||
| EPS Diluted | -302.96% | -79.01% | |||
| Normalized Diluted EPS | -177.03% | -79.34% | |||
| Average Basic Shares Outstanding | 0.21% | 0.60% | |||
| Average Diluted Shares Outstanding | -8.39% | -0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||